GSK plc (GSK.L) Tuesday reported positive headline results from the phase 3 study dubbed GLISTEN evaluating Linerixibat in adults with cholestatic pruritus associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease.
The study met its primary goal by achieving a statistically significant improvement in itch in patients treated with Linerixibat compared with those on placebo.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.